Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lyme arthritis.

Elena M Massarotti1

  • 1Tufts University School of Medicine, Itzhak Perlman Family Arthritis Treatment Center, Division of Rheumatology, New England Medical Center, Boston, Massachusetts, USA. emassarotti@lifespan.org

The Medical Clinics of North America
|May 2, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PD-1 signalling restrains pathogenic T peripheral helper and effector CD4⁺ T cell functions in rheumatoid arthritis.

Annals of the rheumatic diseases·2026
Same author

Safety of CAR T-cell therapy for cancer in pre-existing autoimmune or inflammatory disease: a retrospective comparative cohort study.

The Lancet. Rheumatology·2025
Same author

Clonally expanded CD38<sup>hi</sup> cytotoxic CD8 T cells define the T cell infiltrate in checkpoint inhibitor-associated arthritis.

Science immunology·2023
Same author

Granzyme K<sup>+</sup> CD8 T cells form a core population in inflamed human tissue.

Science translational medicine·2022
Same author

SLAMF7 engagement superactivates macrophages in acute and chronic inflammation.

Science immunology·2022
Same author

A Multianalyte Assay Panel With Cell-Bound Complement Activation Products Predicts Transition of Probable Lupus to American College of Rheumatology-Classified Lupus.

ACR open rheumatology·2021
Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026
Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
See all related articles

Lyme arthritis, caused by Borrelia burgdorferi infection, affects joints like the knee. While often curable with antibiotics, some cases resist treatment due to genetics, requiring alternative therapies.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Rheumatology

Background:

  • Lyme disease, caused by Borrelia burgdorferi, can lead to significant joint inflammation, particularly in the knee.
  • Diagnosis relies on exposure history, clinical signs, and serological tests like ELISA and Western blot.

Observation:

  • While antibiotic therapy is effective for most Lyme arthritis cases, a subset of patients develops treatment-resistant arthritis.
  • The HLA-DR beta 1*0401 haplotype is associated with treatment-resistant Lyme arthritis, necessitating alternative treatments.

Findings:

  • For antibiotic-resistant Lyme arthritis, disease-modifying antirheumatic drugs (DMARDs) like hydroxychloroquine and methotrexate are indicated.
  • Arthroscopic synovectomy is a potential treatment option when antibiotics fail.

Related Experiment Videos

  • Fibromyalgia may occur post-Borrelia burgdorferi infection and is managed with antidepressants and exercise.

    • Implications:

    • Lyme arthritis serves as a crucial model for understanding the pathogenesis of other inflammatory arthropathies, including rheumatoid arthritis.
    • Identifying genetic predispositions like HLA-DR beta 1*0401 can guide personalized treatment strategies for Lyme arthritis.